FDA strengthens AI regulation to ensure patient safety and innovation in healthcare

The FDA is adapting regulations to manage AI’s rapid development in healthcare, focusing on patient safety and the life cycle of AI tools. This review emphasizes the need for continuous monitoring to ensure AI performs effectively in clinical settings.

Sandoz shares dip on first day of Swiss listing after Novartis spinoff

Novartis has completed a spinoff of its generics and biosimilars arm Sandoz, which made its debut earlier today on the SIX Swiss exchange at a

October 5, 2023

Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23.3 million – Biotech Investments

Xlife Sciences AG / Key word(s): Disposal/Investment 18-Oct-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

October 19, 2023

MilliporeSigma opens two mRNA manufacturing facilities

MilliporeSigma’s new large-scale mRNA drug substance manufacturing facility at the company’s headquarters in Darmstadt, Germany. Credit: MilliporeSigma/PRNewswire. Merck’s Life Science business MilliporeSigma has opened two

September 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.